The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Recent reports reveal heart disease is the leading cause of death in the U.S., many of whom are younger than 45. Here's what ...

A growing body of research suggests that mindfulness-based interventions may reduce stress, in turn helping to reduce ...

While common risk factors like high blood pressure, high cholesterol, obesity and smoking are well-known, there are other ...

American Indian and Alaska Native communities are some of the most underserved minoritized groups in the United States, and ...

Cardiovascular diseases are a group of diseases that affect the heart and blood vessels and it includes coronary heart ...

To maintain a healthy heart, researchers say people should focus on diet and exercise, limit alcohol, manage stress, get ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

You might have noticed last week friends and colleagues donning red dresses, shirts and ties for the American Heart ...

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

Heart disease is the number one killer in the U.S., and the risk is even more prevalent in the Black community, reported the ...

This month’s Bon Secours’ Health Matters segment focuses on the impacts of heart disease on women – and how the impacts are different than in men.